In addition, therapies targeting CXCL1, 2, and 8 in the treatment of cancers have been reported [30], [35], [36], and the down-regulation of CXCL1, 2, and 8 inhibited the invasion of tumor cells [32], [35]. Here, CXCL1 is linked to cancer.